Brain tumor

Pediatric Brain Tumors Have a Name: Pediatric Brain Tumor Foundation's Brain Tumor Awareness Month Campaign Spotlights Deadliest Childhood Cancer's Impact on Families

Retrieved on: 
Friday, April 29, 2022
Bayer, Love, Awareness, Life, Long-term care, Program, University of Michigan Rogel Cancer Center, Music, Cancer, Patient, Education, Human, Caregiver, Child, Brain tumor, Brain Tumor Awareness Month, Quality of life, Partnership, Travel, Biomarker, Diagnosis, Hospital, Senior, Multimedia, Interview, Survivor, General manager, Brain, Language, University, Population, Survival, Disease, Geography, Medical imaging, Medicine, Care

PBTF's Brain Tumor Awareness Month campaign "Pediatric Brain Tumors Have a Name" shows that children with brain tumors are more than a statistic.

Key Points: 
  • PBTF's Brain Tumor Awareness Month campaign "Pediatric Brain Tumors Have a Name" shows that children with brain tumors are more than a statistic.
  • On May 19, PBTF will host a Brain Tumor Awareness Month webinar for patient families and health care professionals exploring biomarkers' potential to help families navigate a pediatric brain tumor diagnosis and treatment.
  • Visit www.curethekids.org/stay-connected to learn more about pediatric brain tumors, resources for families, and how to get involved during Brain Tumor Awareness Month and beyond.
  • About the Pediatric Brain Tumor FoundationEvery day, 13 children and teens are diagnosed with a brain tumor, the deadliest childhood cancer.

Global Brain Cancer Therapeutics Market to 2028 - Size, Share, Outlook, and Opportunity Analysis - ResearchAndMarkets.com

Retrieved on: 
Tuesday, April 26, 2022
Pharmaceutical, Health, Oncology, Contra body movement, Cancer, Marketing, Brain, CNS, Central nervous system, CAGR, Neoplasm, US, Sensation, Therapy, Dizziness, Headache, Seizure, Brain tumor, Industry, Memory, Speech, Medical device, Medical imaging

The "The Brain Cancer Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "The Brain Cancer Therapeutics Market - Size, Share, Outlook, and Opportunity Analysis, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
  • Cancer cells grow to form tumor that interfere with brain functions such as muscle control, memory, sensation, and other normal bodily functions.
  • A treatment plan is individualized and planned for each brain cancer patient depending on certain factors.
  • The increasing launches of new drugs and regulatory approvals for brain cancer therapeutics are expected to drive the market growth during the forecast period.

Global Brain Tumor Drugs Market (2022 to 2031) - Featuring Pfizer, Shimadzu and Celgene Among Others - ResearchAndMarkets.com

Retrieved on: 
Thursday, April 7, 2022
Health, Pharmaceutical, Benchmark, Neoplasm, Meningioma, Cisplatin, Glioblastoma, Radiation, Schwannoma, Temozolomide, Lists of diseases, Growth, Coronavirus, Patient, Chemotherapy, Glioma, Everolimus, Cancer, Prevalence, Brain, Medulloblastoma, Regeneration, National Brain Tumor Society, Life expectancy, Carmustine, Infection, PNET, Create, Astrocytoma, Anaplastic astrocytoma, Brain tumor, Marketing, Medical imaging, Oligodendroglioma, Bevacizumab

The brain tumor drugs market consists of sales of drugs which are used to cure a mass growth of abnormal cells in the human brain.

Key Points: 
  • The brain tumor drugs market consists of sales of drugs which are used to cure a mass growth of abnormal cells in the human brain.
  • The main types of drugs in brain tumor drugs are temozolomide, carmustine, cisplatin, bevacizumab, geftinib and erlotinib.
  • The major driving factor responsible for the growth of Brain Tumor market is the increasing prevalence of Neurological Disorders, worldwide.
  • Increasing use of targeted therapies is acting as a restraint on the Brain Tumor drugs market.

Positron Emission Tomography Market is Anticipated to Progress at a CAGR of 6.92%, Assesses DelveInsight

Retrieved on: 
Thursday, March 31, 2022
CAGR, Application, Control, Bruker, Prostate cancer, Cardiology, Google Images, Neurology, Population, USD, PerkinElmer, Diagnosis, Magnetic resonance imaging, General Electric Company, CT, Tissue, Solution, Ageing, CT scan, Positron emission tomography, Brain tumor, Growth, Type, Partial, Reflection, Awareness, Magnetic resonance, PET, Cell, Positron Corporation, Anomaly, LAS, Breast, PET-CT, PSMA, Cancer, Prevalence, Shimadzu, COVID-19, Degenerative disease, MRI, Breast cancer, Canon Medical Systems Corporation, Alzheimer's disease, Hospital, Medical imaging, Epilepsy

LAS VEGAS, March 31, 2022 /PRNewswire/ -- DelveInsight's Positron Emission Tomography Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Positron Emission Tomography companies in the market.

Key Points: 
  • LAS VEGAS, March 31, 2022 /PRNewswire/ -- DelveInsight's Positron Emission Tomography Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Positron Emission Tomography companies in the market.
  • Positron emission tomography uses a radioactive substance positron emission tomography tracer, a specific positron emission tomography camera, and a computer to show both normal and abnormal metabolic activity.
  • The Positron Emission Tomography images are frequently combined with CT or MRI to provide PET-CT (Positron Emission Tomography Computed Tomography) or PET-MRI scans.
  • To know more about why North America is leading the market growth in the Positron Emission Tomography market, get a snapshot of the report Global Positron Emission Tomography Market Outlook
    The Positron Emission Tomography market is witnessing increased product demand for a variety of reasons.

Positron Emission Tomography Market is Anticipated to Progress at a CAGR of 6.92%, Assesses DelveInsight

Retrieved on: 
Thursday, March 31, 2022
CAGR, Application, Control, Bruker, Prostate cancer, Cardiology, Google Images, Neurology, Population, USD, PerkinElmer, Diagnosis, Magnetic resonance imaging, General Electric Company, CT, Tissue, Solution, Ageing, CT scan, Positron emission tomography, Brain tumor, Growth, Type, Partial, Reflection, Awareness, Magnetic resonance, PET, Cell, Positron Corporation, Anomaly, LAS, Breast, PET-CT, PSMA, Cancer, Prevalence, Shimadzu, COVID-19, Degenerative disease, MRI, Breast cancer, Canon Medical Systems Corporation, Alzheimer's disease, Hospital, Medical imaging, Epilepsy

LAS VEGAS, March 31, 2022 /PRNewswire/ -- DelveInsight's Positron Emission Tomography Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Positron Emission Tomography companies in the market.

Key Points: 
  • LAS VEGAS, March 31, 2022 /PRNewswire/ -- DelveInsight's Positron Emission Tomography Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Positron Emission Tomography companies in the market.
  • Positron emission tomography uses a radioactive substance positron emission tomography tracer, a specific positron emission tomography camera, and a computer to show both normal and abnormal metabolic activity.
  • The Positron Emission Tomography images are frequently combined with CT or MRI to provide PET-CT (Positron Emission Tomography Computed Tomography) or PET-MRI scans.
  • To know more about why North America is leading the market growth in the Positron Emission Tomography market, get a snapshot of the report Global Positron Emission Tomography Market Outlook
    The Positron Emission Tomography market is witnessing increased product demand for a variety of reasons.

Global Brain Cancer Markets and Competitive Landscape Report 2021 - ResearchAndMarkets.com

Retrieved on: 
Tuesday, March 22, 2022
Pharmaceutical, Health, Oncology, Clinical Trials, Competitive landscape, Patient, Prevalence, G7, Research, Epidemiology, Brain tumor, Mobile phone, Medical imaging

The "Global Brain Cancer Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Brain Cancer Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Global Brain Cancer Market and Competitive Landscape - 2021, provides comprehensive insights into Brain Cancer pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Brain Cancer treatment options, Brain Cancer late-stage clinical trials pipeline, Brain Cancer prevalence by countries, Brain Cancer market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Brain Cancer market valuations: Find out the market size for Brain Cancer drugs in 2020 by countries.

Brain Cancer Epidemiology Forecast Report 2021-2030 - Focus on US, France, Germany, Italy, Spain, UK, Japan, and Urban China - ResearchAndMarkets.com

Retrieved on: 
Monday, January 31, 2022
Health, Oncology, CNS, Oligodendroglioma, Primary central nervous system lymphoma, Glioma, Cell, C70, Cancer, Central nervous system, Meningioma, National Cancer Institute, Sex, Ependymoma, Epidemiology, Brain, TERT, American Brain Tumor Association, ABTA, BRAF, Glioblastoma, Woman, Man, Malignancy, Recurrence, Biomarker, Neoplasm, Risk, Brain tumor, Incidence, MGMT, Doctor of Philosophy, AGR, Brainstem, C71, Spinal cord, EGFR, Mutation, Mobile phone, Medical imaging, Dietary supplement

The "Brain Cancer - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Brain Cancer - Epidemiology Forecast to 2030" report has been added to ResearchAndMarkets.com's offering.
  • The report includes a 10-year epidemiological forecast for the diagnosed incident cases and five-year diagnosed prevalent cases of brain cancer segmented.
  • The Brain Cancer Epidemiology Report provides an overview of the risk factors and global trends of brain cancer in the eight major markets (8MM: US, France, Germany, Italy, Spain, UK, Japan, and urban China).
  • The report includes a 10-year epidemiological forecast for the diagnosed incident cases and five-year diagnosed prevalent cases of brain cancer segmented.

Brain Cancer Canada To Fund Barrier Breaking Chemistry Research Targeting Glioblastoma

Retrieved on: 
Tuesday, November 30, 2021
Patient, Brain, University, Protein, Canada, GBM, HDAC, Brain tumor, Diagnosis, Traffic barrier, Medicine, HDAC6, Research, GLOBE, Life expectancy, HGG, Quality of life, Medical imaging

The research has identified an approach to potentially breaching barriers that are holding back effective brain cancer therapies.

Key Points: 
  • The research has identified an approach to potentially breaching barriers that are holding back effective brain cancer therapies.
  • Brain Cancer Canada has made these funds available thanks to the generous support from its donors, including Scotia Wealth Management, Yamana Gold, and Hampton Securities.
  • "This is the second time in as many months that we have been able to fund up-and-coming Canadian research through our all-volunteer organization," said Angela Scalisi, Chair of Brain Cancer Canada.
  • To learn more about Brain Cancer Canada, please visit www.braincancercanada.ca
    For inquiries, please contact: Marc Peeters, Director Partnerships and Stakeholders at Brain Cancer Canada, [email protected], 416 918 6678

Global Brain Cancer Diagnostics Market (2021 to 2028) - by Diagnostic Type, Cancer Type, End-user and Geography - ResearchAndMarkets.com

Retrieved on: 
Monday, November 8, 2021
Health, Oncology, Other Health, Society, Mortality, Quality of life, Nausea, Brain, Cancer, Industry, Cancer Research UK, Spinal cord, Neoplasm, CAGR, Headache, Growth, COVID-19, American Society of Clinical Oncology, Fatigue, Hospital Insurance and Diagnostic Services Act, CNS, Woman, Somnolence, ASCO, Geography, Nervous system, Brain tumor, Time, Central nervous system, Prevalence, Cell, Man, Medical imaging, Marketing

The "Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Diagnostic Type, Cancer Type, and End User; and Geography" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Brain Cancer Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis by Diagnostic Type, Cancer Type, and End User; and Geography" report has been added to ResearchAndMarkets.com's offering.
  • The growth of the brain cancer diagnostics market is attributed to factors such as an increase in the prevalence of brain cancer worldwide and technological advancements in brain cancer diagnostics.
  • However, the market is likely to get impacted by the high cost involved in brain cancer diagnostics.
  • Brain cancer is caused due to extracellular growth of the cells in the brain that causes tumors.

Brain Cancer Canada Funds Canadian Research Aiming To Treat Brain Cancer

Retrieved on: 
Sunday, October 24, 2021
Canada, Cancer, Research, Quality of life, Technology, RAS, DRS, Brain tumor, Growth hacking, Child, Patient, Brain, HGG, Adult, Glioblastoma, ISCB Senior Scientist Award, Hospital for Sick Children (Toronto), Cell biology, GLOBE, The Hospital, Pharmaceutical industry, Medical imaging

TORONTO, Oct. 24, 2021 (GLOBE NEWSWIRE) -- Brain Cancer Canada has issued a $100,000 grant to Canadian research exploring new frontiers of brain cancer treatment.

Key Points: 
  • TORONTO, Oct. 24, 2021 (GLOBE NEWSWIRE) -- Brain Cancer Canada has issued a $100,000 grant to Canadian research exploring new frontiers of brain cancer treatment.
  • Less than 3% of all governmental cancer funding is devoted to brain cancer research.
  • "We remain strongly committed to supporting the fight against high-grade gliomas by funding research, treatment and technology," said Brain Cancer Canada chair Angela Scalisi.
  • To learn more about Brain Cancer Canada, please visit www.braincancercanada.ca
    For inquiries, please contact: Marc Peeters, Director Partnerships and Stakeholders at Brain Cancer Canada, [email protected], 416 918 6678